Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells

被引:44
|
作者
Hettinga, JVE
Lemstra, W
Meijer, C
Dam, WA
Uges, DRA
Konings, AWT
DeVries, EGE
Kampinga, HH
机构
[1] UNIV GRONINGEN,DEPT RADIOBIOL,NL-9713 BZ GRONINGEN,NETHERLANDS
[2] UNIV GRONINGEN,DEPT MED ONCOL,NL-9713 BZ GRONINGEN,NETHERLANDS
[3] UNIV GRONINGEN,DEPT HOSP PHARM,NL-9713 BZ GRONINGEN,NETHERLANDS
关键词
thermochemosensitization; cisplatin resistance; cisplatin accumulation; cisplatin-DNA adducts; adduct repair;
D O I
10.1038/bjc.1997.297
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, the mechanism(s) by which heat increases cis-diamminedichloroplatinum (cisplatin, cDDP) sensitivity in cDDP-sensitive and -resistant cell lines of murine as well as human origin were investigated. Heating cells at 43 degrees C during cDDP exposure was found to increase drug accumulation significantly in the cDDP-resisiant cell lines but had little effect on drug accumulation in the cDDP-sensitive cell lines. DNA adduct formation, however, was significantly increased in all cell lines studied. Furthermore, ongoing formation of platinum (Pt)-DNA adducts after the end of cDDP treatment was enhanced and/or adduct removal was decreased in heated cells, resulting in relatively more DNA damage remaining at 24 h after the end of cDDP exposure. Correlation plots with survival revealed weak correlations with cellular Pi accumulation (r(2) = 0.59) and initial Pt-DNA adduct formation (r(2) = 0.64). Strong correlations, however, were found with Pt-DNA adducts at 6 h (r(2) = 0.97) and 24 h (r(2) = 0.89) after the incubation with the drug. In conclusion, the mechanism by which heat sensitizes cells for cDDP action seems to be the sum of multiple factors, which comprise heat effects on accumulation, adduct formation and adduct processing. This mechanism did not seem to differ between cDDP-sensitive and -resistant cells, emphasizing the potential of hyperthemia to reduce cDDP resistance.
引用
收藏
页码:1735 / 1743
页数:9
相关论文
共 50 条
  • [31] Higher induction of heat shock protein 72 by heat stress in cisplatin-resistant than in cisplatin-sensitive cancer cells
    Abe, T
    Gotoh, S
    Higashi, K
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1445 (01): : 123 - 133
  • [32] THE EFFECT OF MALFORMINA1 ON CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT OVARIAN CANCER CELL LINES
    Abdullah, N.
    Al Balushi, N.
    Al-Bahlani, S.
    Dobretsov, S.
    Hassan, I.
    Sang, T.
    Tamimi, Y.
    Burney, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A426 - A426
  • [33] Involvement of Akt/PKB signalling in survival of cisplatin-sensitive and -resistant human pulmonary mesothelioma cells
    Janson, V.
    Trinh, L. T.
    Behnam-Motlagh, P.
    Henriksson, R.
    Grankvist, K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 333 - 334
  • [34] RELATIONSHIP BETWEEN PLATINUM-DNA ADDUCT FORMATION AND REMOVAL AND CISPLATIN CYTOTOXICITY IN CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT HUMAN OVARIAN-CANCER CELLS
    JOHNSON, SW
    SWIGGARD, PA
    HANDEL, LM
    BRENNAN, JM
    GODWIN, AK
    OZOLS, RF
    HAMILTON, TC
    CANCER RESEARCH, 1994, 54 (22) : 5911 - 5916
  • [35] SELECTIVE POTENTIATION OF PLATINUM DRUG CYTOTOXICITY IN CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT HUMAN OVARIAN-CARCINOMA CELL-LINES BY AMPHOTERICIN-B
    SHARP, SY
    MISTRY, P
    VALENTI, MR
    BRYANT, AP
    KELLAND, LR
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 35 (02) : 137 - 143
  • [36] Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells
    Yu, Le
    Wu, William K. K.
    Gu, Chunping
    Zhong, Desheng
    Zhao, Xuyan
    Kong, Yi
    Lin, Qinghuan
    Chan, Matthew T. V.
    Zhou, Zhitao
    Liu, Shuwen
    ONCOTARGET, 2016, 7 (12) : 14693 - 14707
  • [37] Cell cycle perturbations in cisplatin-sensitive and resistant human ovarian carcinoma cells following treatment with cisplatin and low dose rate irradiation
    D. E. Wilkins
    C. E. Ng
    G. P. Raaphorst
    Cancer Chemotherapy and Pharmacology, 1997, 40 : 159 - 166
  • [38] COMPARISON OF PROTEIN-KINASE-C ACTIVITY AND ISOFORM EXPRESSION IN CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT OVARIAN-CARCINOMA CELLS
    BASU, A
    WEIXEL, KM
    INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (04) : 457 - 460
  • [39] mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
    Mabuchi, Seiji
    Kawase, Chiaki
    Altomare, Deborah A.
    Morishige, Kenichirou
    Sawada, Kenjiro
    Hayashi, Masami
    Tsujimoto, Masahiko
    Yamoto, Mareo
    Klein-Szanto, Andres J.
    Schilder, Russell J.
    Ohmichi, Masahide
    Testa, Joseph R.
    Kimura, Tadashi
    CLINICAL CANCER RESEARCH, 2009, 15 (17) : 5404 - 5413
  • [40] Cell cycle perturbations in cisplatin-sensitive and resistant human ovarian carcinoma cells following treatment with cisplatin and low dose rate irradiation
    Wilkins, DE
    Ng, CE
    Raaphorst, GP
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (02) : 159 - 166